A Novel Approach for Image-Guided 131I Therapy of Pancreatic Ductal Adenocarcinoma Using Mesenchymal Stem Cell-Mediated NIS Gene Delivery

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-18-0185
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Image-Based Molecular Phenotyping of Pancreatic Ductal Adenocarcinoma

Journal of Clinical Medicine
2020English

Human Embryonic Stem Cell-Derived Mesenchymal Stem Cells as Cellular Delivery Vehicles for Prodrug Gene Therapy of Glioblastoma

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2011English

752. Pharmacokinetic-Guided Delivery of Mesenchymal Stem Cells

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

A Pilot Trial of Molecularly Tailored Therapy for Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Journal of Pancreatic Cancer
2019English

70. Pancreatic Gene Delivery for Diabetes Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

582. Ultrasound Gene Delivery to Mesenchymal Stem Cells: Targeting Tumor Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2011English

PDE3 Inhibitor and EGCG Combination Treatment Suppress Cancer Stem Cell Properties in Pancreatic Ductal Adenocarcinoma

Scientific Reports
Multidisciplinary
2017English

Can Pharmacogenomics Guide Effective Anticancer Therapy in Pancreatic Ductal Adenocarcinoma?

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2012English

Mesenchymal Stem Cell Secreted Vesicles Provide Novel Opportunities in (Stem) Cell-Free Therapy

Frontiers in Physiology
Physiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy